Inactive Instrument

Highlights Syneos Health, Inc.

Stocks

SYNH

US87166B1026

Biotechnology & Medical Research

Highlights

May. 19	Helio Genomics And Syneos Health Enter Commercial Partnership To Accelerate Nationwide Adoption Of HelioLiver	CI
May. 14	Syneos Health Expands Strategic AI Partnerships	CI
May. 07	CausaLens and Syneos Health Expand Strategic Partnership to Scale Agentic AI in Biopharma Commercialization	CI
Apr. 30	Kai Conversations and Syneos Health Form Strategic Partnership to Advance U.S. Pharmaceutical Commercialization	CI
Mar. 20	Syneos Health, Inc. acquired Shanghai Bestudy Medical Technology Co., Ltd.	CI
25-10-21	Caremetx and Syneos Health Unite to Accelerate Patient Access	CI
24-10-04	CytoDyn Inc. Engages Syneos Health as CRO for Its Phase II Oncology Trial	CI
23-10-03	Syneos Health, Inc. Announces Chief Executive Officer Changes	CI
23-09-28	Syneos Health, Inc. Announces Management Changes	CI
23-09-27	Syneos Health, Inc.'s Equity Buyback announced on June 1, 2022, has expired.	CI
23-09-27	Patient Square Capital, LP, Elliott Investment Management L.P. and Veritas Capital Fund Management, L.L.C completed the acquisition of Syneos Health, Inc. from a group of shareholders.	CI
23-09-12	Syneos Health, Oracle Collaborate to Speed Up Patient Recruitment for Clinical Studies	MT
23-08-16	European Commission Clears Joint Acquisition of Syneos Health	MT
23-08-09	Tranche Update on Syneos Health, Inc.'s Equity Buyback Plan announced on June 1, 2022.	CI
23-08-09	Syneos Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-02	Syneos Health Gets Shareholder Approval for Acquisition Deal	MT
23-08-02	Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health	CI
23-06-26	Syneos Health, uMotif to Collaborate on Digital Platform for Clinical Trials	MT
23-06-26	Syneos Health and uMotif Partner to Deliver Patient-Centric Eclinical Platform	CI
23-05-26	Syneos Health to Collaborate With FivepHusion, Treehill Partners to Develop Chemotherapeutic Product	MT
23-05-10	Elliott, Patient Square and Veritas Reportedly Near Takeover of Syneos	CI
23-05-10	Syneos Health's Q1 Adjusted Earnings Fall, Revenue Rises; Shares Gain	MT
23-05-10	Syneos Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-05-10	Syneos Health Agrees to be Acquired by Private Investment Firm Consortium in $7.1 Billion Deal; Shares Rise Pre-Bell	MT
23-05-10	Earnings Flash (SYNH) SYNEOS HEALTH Reports Q1 Revenue $1.36B, vs. Street Est of $1.282B	MT